Cite

    Jang, G. et al. (n.d.). A clinical therapeutic protein drug–drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis. Pharmacology research & perspectives. 2 (2), p. n/a. [Online].